Top 6 At-Home Exosome Serums Compared: Plant vs Stem-Cell Derived (2026)
By Dr. Mei Chen · Cosmetic Dermatologist & Senior Editor, The Exosome Edit
Updated Jun 2026The exosome category exploded in 2024 and 2025. In May 2026 it sits in a strange place.
Quick Answer
- The FDA has approved zero exosome products. None. Topical "exosome" claims are marketing.
- Plant exosomes (rose, Centella) have small case-series evidence. Animal stem-cell exosomes have more.
- Best Korea-validated formula: ExoCobio ASCE+. Best US clinical pedigree: Plated INTENSE.
- If skeptical: skip exosome serums. Try a propolis + niacinamide serum instead.
Disclosure: this article contains affiliate links — we may earn a commission on qualifying purchases at no extra cost to you.
Last updated: May 2026
Medical Disclaimer: This article is educational, not medical advice. Topical exosome products are sold as a cosmetics in the US — not as drugs. Consult a board-certified dermatologist for personalized recommendations.
Affiliate Disclosure: The Exosome Edit may earn a small commission on products linked at no extra cost to you. Editorial picks are independent.
At a glance: 10 serums ranked
| Rank | Serum | Exosome Source | Price (USD) | Verdict |
|---|---|---|---|---|
| 1 | ExoCobio ASCE+ DR Cell Sphere | Rose plant stem cell | $180-$240 | Best Korea-validated formula |
| 2 | Plated INTENSE Serum | Human platelet | $300 | Best US clinical pedigree |
| 3 | Calecim Multi-Action Cream | Red deer umbilical cord | $250 | Best post-procedure cream |
| 4 | Skin1004 Madagascar Centella Exosome | Centella plant-derived | $28 | Best budget K-beauty |
| 5 | Numbuzin No. 9 NAD+ Lifting | Peptide + NAD+ (no exosome) | $33 | Honest re-label of No. 9 line |
| 6 | Beauty of Joseon Glow Serum | Propolis + niacinamide | $17 | Best honest alternative |
What we looked at
The exosome category exploded in 2024 and 2025. In May 2026 it sits in a strange place.
Real research keeps coming. Rose stem-cell exosomes show wound-healing benefit in small case series (PMC, 2024).
But the regulatory floor is also clear. The FDA has approved zero exosome products for any use, a cosmetic or medical, as of May 2026.
Every "exosome serum" you can buy at home is marketed as a cosmetic (FDA Public Safety Notification, 2023). That means no FDA-reviewed efficacy claims, no FDA-reviewed dosing, no FDA-reviewed manufacturing standards.
This list ranks 10 serums commonly marketed as "exosome" or sold next to that category. Three of them don't actually claim exosomes — they're honest contrast picks.
I've practiced a cosmetic derm for 11 years. My bias: I'd rather a patient buy a $17 propolis serum that does something real than a $300 vial of nanovesicles that may or may not penetrate intact stratum corneum.
The FDA has issued multiple warning letters about exosome products marketed with therapeutic claims (FDA Warning Letters, 2024-2025).
1. ExoCobio Asce+ DR Cell Sphere Active Serum — K-Beauty Pioneer (Verdict: Best for Korea-validated formula)
ExoCobio sits at the top because it built the category. The Seoul-based biotech holds key patents on rose stem-cell exosome isolation via its ExoSCRT technology (ASCE+, 2026).
The Cell Sphere Active Serum sells direct in the US for around $180-$240 depending on retailer. The formula contains rose stem-cell exosomes alongside high-molecular hyaluronic acid, 10 growth factors, 6 peptides, NAD+, and glutathione (Laboderm Skin, 2025).
The Korean clinical evidence comes from in-office injectable use, not the topical serum. That's an important distinction. Korean dermatologists pair the powder formula with microneedling in-clinic, then send patients home with the topical for maintenance.
There's no published RCT on the topical serum alone. FDA stance: ExoCobio sells the topical in the US as a cosmetic. The injectable powder is not FDA-approved for any use here.
Brand HQ: Seoul. Best for: post-procedure recovery at home, patients who've already had in-office exosome treatments.
The Korean MFDS approval pathway is different from the FDA's. Korean a cosmetic regulators allow more functional claims than the US framework. US patients should treat the topical as a high-level peptide-and-hyaluronic-acid serum with rose-exosome adjacency, not as a repair drug.
2. Plated Skin Science INTENSE Serum — US Clinical Pedigree (Verdict: Best US-developed pick)
Plated comes out of Mayo Clinic research. Co-founded by a Mayo Clinic dermatologist, the INTENSE Serum runs $300 for a one-month supply on the brand site. The formula delivers what Plated calls 15 billion platelet exosomes per pump (Plated Skin Science, 2026).
It uses human platelet exosomes — not stem cell, not plant. Platelets are easier to source ethically and faster to scale than stem cell tissues.
The brand cites a clinical study showing 2x younger-looking skin and visible wrinkle reduction at six weeks. The study is brand-sponsored, not studied in a major derm journal. Awards include 2025 NewBeauty Best Exosome Serum and 2025 Cosmopolitan Holy Grail.
FDA stance: marketed as a cosmetic, not FDA-approved as a drug. Mayo Clinic Store carries it (Mayo Clinic Store, 2026) — that's the closest thing to institutional vetting in this category.
Brand HQ: Rochester, MN. Plated recommends a 6-to-12-week treatment course rather than indefinite use.
That intermittent approach is honest. Most brands push daily-forever positioning that doesn't match the underlying biology. Best for: patients with $300 to spend on a 6-week repair push, ideally stacked with monthly in-office work like microneedling or PRP (platelet-rich plasma).
3. Calecim Multi-Action Cream — Post-Procedure Cream (Verdict: Best for downtime recovery)
Calecim Professional uses cord-lining stem cells from red deer — yes, red deer (Calecim Professional, 2026). Their patented PTT-6 complex contains over 3,000 proteins including growth factors, cytokines, and exosomes.
The Multi-Action Cream runs about $250 at authorized retailers. It's 50% Cord Lining Conditioned Media — that's a serious level.
Calecim has been around longer than most. CellResearchCorp, the parent company, holds patents on the cord-lining isolation method dating back over 20 years. Many US derms use it as the official aftercare for laser and microneedling.
FDA stance: sold as a cosmetic. Not FDA-approved for any therapeutic claim. The animal-derived sourcing turns off some patients — others find it less ethically fraught than human umbilical cord products.
Brand HQ: Singapore. Calecim's positioning around post-procedure recovery is the strongest in the category.
Multiple US plastic-surgery practices include the Multi-Action Cream in their aftercare bundles for ablative laser and deep microneedling. The 50% conditioned-media level is high enough that even partial topical penetration delivers real barrier-soothing benefit.
Best for: patients planning RF microneedling, fractional laser, Morpheus8, or moderate chemical peels within the next 30 days. Works well as a bridge between in-office sessions of Sculptra or Hydrafacial.
4. Skin1004 Madagascar Centella Exosome — Budget K-Beauty (Verdict: Best under $30 pick)
Skin1004 made its name with the Madagascar Centella Ampoule. The original is a 100% Centella Asiatica serum that's been a K-beauty cult favorite for years (Skin1004, 2026).
The exosome variant adds plant-derived exosomes to the same Centella base. Price hovers around $28 on Amazon and YesStyle.
Centella Asiatica has real anti-inflammatory data going back decades. Madecassoside and TECA — the active triterpenes — have studied wound-healing evidence. The added "exosome" claim is the marketing layer.
FDA stance: sold as a cosmetic. No specific FDA action against Skin1004's exosome claims. Brand HQ: Seoul.
Best for: budget-conscious patients who want the Centella benefits and treat the exosome content as a bonus, not the main event.
5. Numbuzin No. 9 NAD+ Lifting Essence — Honest Re-label (Verdict: Skip if you want exosomes specifically)
Including this for honesty. Numbuzin's No. 9 NAD+ BIO Lifting-sil Essence is often shelved next to exosome products but contains no exosome claim (Numbuzin US, 2026).
It runs $33 on the brand US site. The active stack is NAD+ plus 50 peptides — both well-studied for cellular signaling.
NAD+ has stronger published evidence in topical formulas than most plant exosomes. Peptide stacks are mature chemistry. If you're drawn to exosome marketing for the repair angle, a NAD+ + peptide serum gives you real mechanism at one-tenth the price.
FDA stance: sold as a cosmetic. Brand HQ: Seoul. Best for: patients who want repair-leaning skincare without paying exosome prices.
6. Beauty of Joseon Glow Serum — Most Honest Alternative (Verdict: Best value in the category)
This is the contrast pick. Beauty of Joseon's Glow Serum contains no exosomes. It's 60% propolis extract plus 2% niacinamide and 0.5% BHA — period (Beauty of Joseon, 2026).
Price: $17 for 30ml on iHerb and Amazon. Every active is well-studied.
Niacinamide at 2-5% has decades of RCT data for barrier function, pigmentation, and pore appearance (Incidecoder, 2026). Propolis has antimicrobial and anti-inflammatory evidence. BHA exfoliates measurably.
I include this because the honest comparison matters. A patient with $300 to spend can buy 17 bottles of this and have actives with studied evidence — or one bottle of Plated INTENSE with brand-sponsored data. Both choices are valid.
The math just deserves disclosure. FDA stance: a cosmetic, like everything else here. Best for: patients who want real actives at honest prices.
How we evaluated each label
Most exosome serum labels are not transparent. The category leans on proprietary-complex language that hides exosome counts and source-cell details.
Three things to scan for before paying $100+ for a bottle.
Exosome count per ml. Legitimate brands disclose. ExoCobio publishes 5 billion exosomes per vial. Plated publishes 15 billion per pump.
Brands that won't quote a number are usually hiding low levels. Anything labeled "contains exosomes" without quantification is a red flag.
Source cell and tissue origin. Plant stem cell from rose, Centella, or edelweiss. Or human platelet. Or mammalian umbilical cord.
Each has different cargo and different regulatory exposure. If the label says "stem cell exosomes" without specifying species and tissue, the brand is being evasive.
Supporting actives at clinical levels. Niacinamide at 2-5%, peptides at quantified levels, hyaluronic acid molecular weight ranges. These are the ingredients with actual studied topical evidence.
If they're at useful levels, the serum works even if the exosome claim doesn't hold up. This is how SkinMedica built its name — quantified actives, published trials, open INCI lists.
Bottom line: who should skip this category
Honest answer: most patients. The published evidence for at-home topical exosome serums is weak relative to the price tag.
Three groups in particular should redirect their skincare budget.
Patients with active rosacea, perioral dermatitis, or compromised barriers. Many exosome serums stack other actives — peptides, growth factors, antioxidant complexes — that themselves cause irritation. A simple barrier-repair routine with ceramides, panthenol, and centella beats an exosome serum for this group.
Patients on tight skincare budgets. A $17 niacinamide-based serum delivers more real benefit than a $250 exosome cream for most concerns. The opportunity cost matters.
Spend the $250 on three sessions of in-office treatment instead. Or on a year of well-studied actives like retinoids and vitamin C.
Patients without a repair-skincare baseline. If you're not already using SPF 30+ daily, a topical antioxidant, and either Retin-A (tretinoin), Differin (adapalene), or a peptide serum, an exosome serum is not the gap.
The fundamentals deliver 80% of the benefit at 10% of the cost. Build the SkinMedica baseline first, then layer exosomes as the finishing experiment. BeautyStat Universal C Skin Refiner makes a solid antioxidant base if you're starting from zero. Skinuva Scar offers stronger scar-specific evidence than any topical exosome.
Frequently Asked Questions
What is the FDA stance on exosome serums in 2026?
The FDA has approved zero exosome products for any use, a cosmetic or medical. Topical exosome serums are sold as a cosmetics in the US, meaning brands cannot make therapeutic claims like "treats wrinkles" or "repairerates skin." The agency issued public safety alerts in 2019, 2020, and 2023, and has sent at least six warning letters to companies marketing exosome products with drug claims, most recently in late 2024 and September 2025 (FDA, 2025). Topical a cosmetic products are subject to lower regulatory scrutiny than injectables, but a cosmetic claims still cannot cross into drug territory.
Do topical exosomes actually penetrate intact skin?
Limited evidence. Plant-derived exosomes are small enough to cross biological barriers in lab settings (PMC, 2024). Whether they cross intact human stratum corneum at clinically meaningful levels is unresolved. The strongest topical data comes from microneedling protocols where exosomes are applied to skin with mechanical channels. Topical-only application without microneedling has weaker published evidence. Several derm reviews in 2025 noted that the at-home topical penetration question remains the central open scientific issue in the category.
Plant vs animal exosomes — which is better?
Different tradeoffs. Plant exosomes (rose, Centella, edelweiss) have low immunogenicity and easier sourcing — the published case-series evidence is small but growing, with a 2024 Rosa damascena study showing wound-healing benefit in retrospective review. Animal stem-cell exosomes (umbilical cord, platelet) carry more complex cargo and have more published research overall, but raise sourcing-ethics questions and tighter FDA scrutiny. Neither has a published head-to-head RCT in at-home topical use as of May 2026.
Is the clinical evidence for at-home exosome serums strong?
Mostly weak. Most brand-cited clinical data is in vitro (lab dish) or brand-sponsored. Peer-reviewed RCTs on at-home topical exosome serums are scarce. The strongest derm evidence is for in-office injectable use combined with microneedling, not at-home topical use alone (Salisbury Plastic Surgery, 2025). Patients who want repair skincare with stronger evidence should look at retinoids, peptide serums, and growth-factor serums with studied RCT data going back years.
How do exosome serums compare to growth-factor serums?
Growth-factor serums have a longer track record. SkinMedica TNS Essential Serum, BeautyStat Universal C, ISDIN Isdinceutics, and similar have studied data going back to the 2010s. Exosomes carry growth factors plus signaling RNAs, in theory making them more bioactive than growth factors alone. In practice, the topical penetration question hits both categories. For at-home use with the strongest evidence base, a growth-factor serum from SkinMedica or a retinoid like Retin-A (tretinoin) or Differin (adapalene) remains the conservative pick. Rion Aesthetics also produces a respected exosome topical line worth comparing. Patients drawn to the exosome marketing for the repair angle are often better served by a well-formulated peptide or growth-factor serum at half the price.
Related Reading
- Salmon-DNA vs Stem Cell Exosomes: 2026 Performance Comparison
- Topical vs Injectable Exosomes: 2026 Guide
- Best Regenerative Skincare for Post-Procedure Recovery (2026)
-- The Exosome Edit Team
META_DESCRIPTION: Compared: 10 at-home exosome serums. Exosome source, other actives, price, evidence, FDA stance, and verdict for each.